Literature DB >> 6201541

Characteristics of human NK clones: target specificity and phenotype.

P Allavena, J R Ortaldo.   

Abstract

Clones derived from purified human large granular lymphocytes (LGL) of three different donors were expanded in culture medium supplemented with interleukin 2 (IL 2). Their cytotoxic activity was tested in a 51Cr-release cytotoxicity assay against a panel of three to five NK-susceptible tumor cell lines. Of 196 LGL clones tested, only 44 (22.4%) displayed significant cytotoxic activity. A heterogeneous pattern of reactivity was seen; 26 clones (59%) killed all the targets within the panel tested, whereas 18 clones (41%) had a more restricted specificity. Among these 18 clones, 12 lysed only one target (K562, six clones; ADCC, three clones; Daudi, two clones; MOLT-4, one clone), whereas the other six killed two different targets (ADCC and A1ab, one clone; K562 and MOLT-4, five clones). Clones derived from LGL preselected for positive reactivity with the monoclonal antibodies (MoAb) alpha OKM1, alpha OKT10 and alpha B73.1 also demonstrated either broad or restricted patterns of cytotoxicity. The LGL reactive with MoAb alpha B73.1 gave a high percentage of cytotoxic clones. Phenotype analysis showed that clones could express both antigens associated with T cells (i.e., OKT3, OKT4, and OKT8) and antigens shared by LGL (i.e., OKM1, OKT10, and B73.1). The pattern of surface markers varied considerably among the clones; however, no clear correlation between the pattern of antigenic phenotype and cytotoxic activity was seen. These data show that clones derives from purified preparations of LGL present different functional and antigenic characteristics, and support the hypothesis that the heterogeneity of the entire NK population is attributable, at least in part, to a mixture of clones that vary substantially in their target specificities and phenotypes.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6201541

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  17 in total

1.  Functional surface structures on human natural killer cells.

Authors:  R E Schmidt; T Hercend; S F Schlossman; J Ritz
Journal:  Klin Wochenschr       Date:  1985-12-02

Review 2.  Human thymic and peripheral blood non-MHC-restricted cytotoxic lymphocytes.

Authors:  L L Lanier; J H Phillips
Journal:  Med Oncol Tumor Pharmacother       Date:  1986

Review 3.  Regulation of natural killer activity.

Authors:  J R Ortaldo
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

4.  In vitro proliferation of human large granular lymphocytes with v-raf/v-myc recombinant retrovirus.

Authors:  S Peppoloni; E Blasi; J R Ortaldo; U R Rapp; C Riccardi; L Varesio
Journal:  Experientia       Date:  1988-12-01

5.  Natural cytotoxicity in the neonate: high levels of lymphokine activated killer (LAK) activity.

Authors:  D Montagna; R Maccario; A G Ugazio; G Mingrat; G R Burgio
Journal:  Clin Exp Immunol       Date:  1988-01       Impact factor: 4.330

6.  Phenotypic and functional analysis of lymphokine-activated killer (LAK) cell clones. Ability of CD3+, LAK cell clones to produce interferon-gamma and tumor necrosis factor upon stimulation with tumor targets.

Authors:  A S Chong; A Aleksijevic; P Scuderi; E M Hersh; W J Grimes
Journal:  Cancer Immunol Immunother       Date:  1989       Impact factor: 6.968

7.  Human interleukin-2 activated cytotoxic cells kill autologous glioma cells in vitro.

Authors:  V Bosnes; H Hirschberg
Journal:  J Neurooncol       Date:  1988       Impact factor: 4.130

8.  Coexpression of Fc gamma receptor IIIA and interleukin-2 receptor beta chain by a subset of human CD3+/CD8+/CD11b+ lymphocytes.

Authors:  S Zupo; L Azzoni; R Massara; A D'Amato; B Perussia; M Ferrarini
Journal:  J Clin Immunol       Date:  1993-05       Impact factor: 8.317

9.  In search of specific cytotoxic T lymphocytes infiltrating or accompanying human ovarian carcinoma.

Authors:  M Apiranthitou-Drogari; C Paganin; S Bernasconi; G Losa; A Maneo; N Colombo; A Mantovani; P Allavena
Journal:  Cancer Immunol Immunother       Date:  1992       Impact factor: 6.968

10.  Production of multiple cytokines by clones of human large granular lymphocytes.

Authors:  P Allavena; G Scala; J Y Djeu; A D Procopio; J J Oppenheim; R B Herberman; J R Ortaldo
Journal:  Cancer Immunol Immunother       Date:  1985       Impact factor: 6.968

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.